Investor Ideas ‘Potcast’; #Cannabis News
and Stocks on the Move; (CSE: $GLH.C), (CSE: $AFI.C), (CSE: $ATT.C), (TSXV:
$CBW.V)
Pt. Roberts, WA; Delta, BC – May 17, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of
its new series, Investorideas.com potcasts - cannabis news and stocks to watch plus
insight from thought leaders and experts.
Listen to the podcast:
Read this in full at http://www.investorideas.com/news/2018/cannabis/05175Potcast-StocksToWatch.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to
Investorideas.com potcasts- following cannabis news, stocks to watch as
well as insight from thought leaders and experts. Today we looking at
announcements from Golden Leaf Holdings LTD trading on the CSE as GLH and the OTCQB as GLDFF, Affinor Growers LTD trading on the CSE as AFI and OTC as RSSFF, Abattis Bioceuticals Corp trading on the CSE as ATT and OTC as ATTBF and Cannabis Wheaton Income Corp. trading on the TSX-Venture
under CBW
Starting with Golden Leaf Holdings Ltd., a leading cannabis oil
solutions company built around recognized brands, announced that it has signed
a letter of intent to acquire two large cannabis cultivation facilities and
their associated cultivation licenses, one in Northern Nevada and the other in
Northern California, that are owned by the same operators. The Nevada facility
is currently operational and generating positive cash flow, and the California
facility is provisionally licensed for cultivation.
Under the terms of
the LOI, Golden Leaf would pay US$8.5 million in cash at closing, plus an as of
yet undetermined number of shares that equals 25% of the total issued and
outstanding shares of common stock of GLH on the closing date.
"Signing this
LOI provides Golden Leaf with an opportunity to secure an agreement that would
significantly expand our cultivation capabilities in the high-growth Nevada and
California markets, both of which have commenced adult-use sales within the
past 12 months," commented William Simpson, CEO of Golden Leaf.
Next looking at Affinor Growers Ltd who
announce they have signed a definitive license agreement , with a later stage
Licensed Producer Applicant in British Columbia. The license represents
royalties of 3% of all products grown using the patented technology and gives
the exclusive rights for Vancouver Island for Fruits, Vegetables and Marijuana
once the Health Canada license is achieved, to grow, process, import and export
Marijuana. The 15,000 sqft greenhouse slated to be completed by end of 2018
will house up to 48 full scale towers to service Vancouver Island with high
quality, low priced organic pharma grade marijuana while diversifying into
organic food production to showcase more sustainable practices in Canada. This
is expected to create job’s, education, training, and supports agriculture
programs on Vancouver Island with clean fresh organic products grown all year
using the patented Affinor Growers Vertical Farming Tower Technology.
Affinor is also in
the process of setting up a single vertical growing tower in Abbotsford for the
purpose of completing a second phase test and improving efficiencies in growing
Marijuana using the vertical growing tower technology developed by Affinor. The
original test was completed in 2017 and was a success based on the increases in
production using the vertical tower technology. Both of these tests are being
done under medical marijuana licenses currently in good standing.
Abattis Bioceuticals Corp. also
had an announcement that it has entered into a non-binding letter of intent
with Cannamedix Inc. to provide Cannamedix with, pesticide-free
cannabinoid-containing oils, research and development, analytical and
regulatory services and access to Abattis’s distribution and marketing channels
to support the development and commercialization of new CBD-infused
nutraceuticals and natural health products. Cannamedix is a Calgary-based
healthcare provider focused on the use of traditional and alternative therapies
to address health conditions, from pain management to integrative cancer care.
"Cannamedix’s
plans to develop a new and compliant line of CBD-containing products is
consistent with the fast adoption of cannabinoid-based medicine we have seen
across North America, Europe and Australia," stated Dr. David Galvez,
Senior Science Advisor at Abattis.
And finally looking at Cannabis Wheaton Income Corp. who announced that it has closed its previously
announced acquisition of all of the outstanding securities of Dosecann Inc., a
late-stage “Licensed Dealer” applicant pursuant to the NCR.
Dosecann is
expected to serve a critical role in the “mid-stream” segment of Cannabis
Wheaton’s platform. Dosecann will be the Company’s primary facility for various
value enhancing intellectual property related activities such as extraction,
processing, branding and licensing, product development and manufacturing,
research and development, and various international opportunities. The Company
also intends to utilize the Dosecann facility for the commercialization of
various cannabis products available under the Company’s recently announced
license agreement with Dixie Brands, Inc., as permitted by applicable law.
Hugo Alves, President and
Director of Cannabis Wheaton stated, “The addition of Dosecann to the Cannabis
Wheaton platform provides us with a strategic regulatory tool that we believe
will be increasingly important under the proposed Cannabis Act. We couldn’t be
more excited to be working with the high caliber team Greg Boone has put
together to develop Dosecann into a true ‘center of excellence’ in the creation
of intellectual property, product development and commercialization. We believe
the Dosecann team’s proven ability to take pharmaceutical, natural health
products, and consumer packaged goods from conceptualization to
commercialization will be of huge value to the Company’s wholly owned
subsidiaries and streaming partners as we enter the next leg of growth in the
domestic and international markets for cannabis products.”
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the Investorideas.com news and stock
directory pages, a cannabis investor group on Linkedin.com , the 420 Cannabis
Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
To sponsor this podcast or be a guest
Contact Investorideas.com
800-665-0411
